Literature DB >> 25897078

Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1.

Ulrike Binsker1, Thomas P Kohler2, Krystin Krauel3, Sylvia Kohler1, Hansjörg Schwertz3, Sven Hammerschmidt1.   

Abstract

The human matricellular glycoprotein thrombospondin-1 (hTSP-1) is released by activated platelets and mediates adhesion of Gram-positive bacteria to various host cells. In staphylococci, the adhesins extracellular adherence protein (Eap) and autolysin (Atl), both surface-exposed proteins containing repeating structures, were shown to be involved in the acquisition of hTSP-1 to the bacterial surface. The interaction partner(s) on the pneumococcal surface was hitherto unknown. Here, we demonstrate for the first time that pneumococcal adherence and virulence factor B (PavB) and pneumococcal surface protein C (PspC) are key players for the interaction of Streptococcus pneumoniae with matricellular hTSP-1. PavB and PspC are pneumococcal surface-exposed adhesins and virulence factors exhibiting repetitive sequences in their core structure. Heterologously expressed fragments of PavB and PspC containing repetitive structures exhibit hTSP-1 binding activity as shown by ELISA and surface plasmon resonance studies. Binding of hTSP-1 is charge-dependent and inhibited by heparin. Importantly, the deficiency in PavB and PspC reduces the recruitment of soluble hTSP-1 by pneumococci and decreases hTSP-1-mediated pneumococcal adherence to human epithelial cells. Platelet activation assays suggested that PavB and PspC are not involved in the activation of purified human platelets by pneumococci. In conclusion, this study indicates a pivotal role of PavB and PspC for pneumococcal recruitment of soluble hTSP-1 to the bacterial surface and binding of pneumococci to host cell-bound hTSP-1 during adhesion.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  MSCRAMMs; adhesin; bacterial pathogenesis; extracellular matrix protein; platelet; pneumococci; thrombospondin

Mesh:

Substances:

Year:  2015        PMID: 25897078      PMCID: PMC4505522          DOI: 10.1074/jbc.M114.623876

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Authors:  Carlos J Orihuela; Jafar Mahdavi; Justin Thornton; Beth Mann; Karl G Wooldridge; Noha Abouseada; Neil J Oldfield; Tim Self; Dlawer A A Ala'Aldeen; Elaine I Tuomanen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

Review 2.  Proteoglycans: from structural compounds to signaling molecules.

Authors:  Liliana Schaefer; Roland M Schaefer
Journal:  Cell Tissue Res       Date:  2009-06-10       Impact factor: 5.249

3.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Thrombocytopenia in a surgical ICU.

Authors:  F Stéphan; J Hollande; O Richard; A Cheffi; M Maier-Redelsperger; A Flahault
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

5.  The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Authors:  M T Rondina; H Schwertz; E S Harris; B F Kraemer; R A Campbell; N Mackman; C K Grissom; A S Weyrich; G A Zimmerman
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

6.  Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif.

Authors:  S Hammerschmidt; M P Tillig; S Wolff; J P Vaerman; G S Chhatwal
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

7.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.

Authors:  Aaron L Nelson; Aoife M Roche; Jane M Gould; Kannie Chim; Adam J Ratner; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

Review 9.  Current understanding of the thrombospondin-1 interactome.

Authors:  Andrea Resovi; Denise Pinessi; Giovanna Chiorino; Giulia Taraboletti
Journal:  Matrix Biol       Date:  2014-01-27       Impact factor: 11.583

10.  Staphylococcal extracellular adherence protein induces platelet activation by stimulation of thiol isomerases.

Authors:  Anne Bertling; Silke Niemann; Muzaffar Hussain; Lisa Holbrook; Ronald G Stanley; Martin F Brodde; Silke Pohl; Tina Schifferdecker; Joachim Roth; Kerstin Jurk; Anja Müller; Judith Lahav; Georg Peters; Christine Heilmann; Jonathan M Gibbins; Beate E Kehrel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

View more
  13 in total

Review 1.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria.

Authors:  Ulrike Binsker; Thomas P Kohler; Sven Hammerschmidt
Journal:  J Innate Immun       Date:  2019-02-27       Impact factor: 7.349

2.  Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic.

Authors:  Ulrike Binsker; Thomas P Kohler; Krystin Krauel; Sylvia Kohler; Johanna Habermeyer; Hansjörg Schwertz; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

Review 3.  The matricellular protein thrombospondin-1 in lung inflammation and injury.

Authors:  Mohammadreza Tabary; Atish Gheware; Hernán F Peñaloza; Janet S Lee
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

4.  The Pneumococcal Surface Proteins PspA and PspC Sequester Host C4-Binding Protein To Inactivate Complement C4b on the Bacterial Surface.

Authors:  Kashif S Haleem; Youssif M Ali; Hasan Yesilkaya; Thomas Kohler; Sven Hammerschmidt; Peter W Andrew; Wilhelm J Schwaeble; Nicholas J Lynch
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

5.  Modular Architecture and Unique Teichoic Acid Recognition Features of Choline-Binding Protein L (CbpL) Contributing to Pneumococcal Pathogenesis.

Authors:  Javier Gutiérrez-Fernández; Malek Saleh; Martín Alcorlo; Alejandro Gómez-Mejía; David Pantoja-Uceda; Miguel A Treviño; Franziska Voß; Mohammed R Abdullah; Sergio Galán-Bartual; Jolien Seinen; Pedro A Sánchez-Murcia; Federico Gago; Marta Bruix; Sven Hammerschmidt; Juan A Hermoso
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

Review 6.  Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

Authors:  Greiciely O Andre; Thiago R Converso; Walter R Politano; Lucio F C Ferraz; Marcelo L Ribeiro; Luciana C C Leite; Michelle Darrieux
Journal:  Front Microbiol       Date:  2017-02-20       Impact factor: 5.640

7.  Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis.

Authors:  Ofer Prager; Alon Friedman; Yaffa Mizrachi Nebenzahl
Journal:  Exp Ther Med       Date:  2017-01-24       Impact factor: 2.447

Review 8.  Fibronectin and Its Role in Human Infective Diseases.

Authors:  Pietro Speziale; Carla Renata Arciola; Giampiero Pietrocola
Journal:  Cells       Date:  2019-11-26       Impact factor: 6.600

9.  Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.

Authors:  Akiko Jinno; Atsuko Hayashida; Howard F Jenkinson; Pyong Woo Park
Journal:  mBio       Date:  2020-12-08       Impact factor: 7.867

10.  Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine.

Authors:  Yaffa Mizrachi Nebenzahl; Karin Blau; Tatyana Kushnir; Marilou Shagan; Maxim Portnoi; Aviad Cohen; Shalhevet Azriel; Itai Malka; Asad Adawi; Daniel Kafka; Shahar Dotan; Gali Guterman; Shany Troib; Tali Fishilevich; Jonathan M Gershoni; Alex Braiman; Andrea M Mitchell; Timothy J Mitchell; Nurith Porat; Inna Goliand; Vered Chalifa Caspi; Edwin Swiatlo; Michael Tal; Ronald Ellis; Natalie Elia; Ron Dagan
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.